|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/06/20 Abiomed Inc 10-Q 12/31/19 85:13M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.29M
2: EX-3.2.1 Articles of Incorporation/Organization or Bylaws HTML 181K
3: EX-3.2.2 Articles of Incorporation/Organization or Bylaws HTML 204K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 28K
79: R1 Document and Entity Information HTML 78K
32: R2 Condensed Consolidated Balance Sheets HTML 122K
22: R3 Condensed Consolidated Balance Sheets HTML 47K
(Parenthetical)
55: R4 Condensed Consolidated Statements of Operations HTML 82K
78: R5 Condensed Consolidated Statements of Comprehensive HTML 49K
Income
31: R6 Condensed Consolidated Statements of Stockholders' HTML 124K
Equity
21: R7 Condensed Consolidated Statements of Cash Flows HTML 123K
54: R8 Nature of Business HTML 29K
80: R9 Basis of Preparation and Summary of Significant HTML 34K
Accounting Policies
58: R10 Net Income Per Share HTML 127K
81: R11 Revenue Recognition HTML 127K
40: R12 Financial Instruments HTML 504K
29: R13 Property and Equipment HTML 63K
59: R14 Goodwill, In-Process Research and Development and HTML 139K
Other Assets
82: R15 Leases HTML 94K
41: R16 Accrued Expenses HTML 59K
30: R17 Stockholders' Equity HTML 165K
57: R18 Stock-Based Compensation HTML 215K
83: R19 Income Taxes HTML 104K
42: R20 Commitments and Contingencies HTML 45K
14: R21 Segment and Enterprise Wide Disclosures HTML 29K
62: R22 Basis of Preparation and Summary of Significant HTML 112K
Accounting Policies (Policies)
69: R23 Net Income Per Share (Tables) HTML 125K
43: R24 Revenue Recognition (Tables) HTML 92K
15: R25 Financial Instruments (Tables) HTML 506K
63: R26 Property and Equipment (Tables) HTML 63K
70: R27 Goodwill, In-Process Research and Development and HTML 138K
Other Assets (Tables)
44: R28 Leases (Tables) HTML 91K
12: R29 Accrued Expenses (Tables) HTML 58K
27: R30 Stockholders' Equity (Tables) HTML 166K
39: R31 Stock-Based Compensation (Tables) HTML 220K
85: R32 Income Taxes (Tables) HTML 99K
61: R33 Computation of Basic and Diluted Net Income Per HTML 54K
Share (Detail)
26: R34 Net Income Per Share - Additional Information HTML 28K
(Detail)
38: R35 Revenue Recognition - Schedule of Categorizes HTML 37K
Revenue by Major Business Line (Detail)
84: R36 Revenue Recognition - Terms - Additional HTML 39K
Information (Detail)
60: R37 Revenue Recognition - Deferred Revenue - HTML 30K
Additional Information (Detail)
28: R38 Cash Equivalents and Marketable Securities HTML 34K
(Detail)
37: R39 Investable Cash Equivalents and Marketable HTML 60K
Securities (Detail)
19: R40 Financial Instruments - Additional Information HTML 44K
(Detail)
50: R41 Schedule of Cross-Currency Rate Swap Derivatives HTML 35K
(Detail)
72: R42 Schedule of Fair Value of Company's Derivative HTML 29K
Instrument (Detail)
65: R43 Financial Instruments Measured at Fair Value HTML 75K
(Detail)
18: R44 Valuation Method Used to Calculate Level 3 HTML 73K
Liabilities Measured at Estimated Fair Value of
Contingent Consideration Related to Acquisition
(Detail)
49: R45 Change in Fair Value of Contingent Consideration HTML 40K
as Determined by Level 3 Inputs (Detail)
71: R46 Components of Property and Equipment (Detail) HTML 50K
64: R47 Goodwill, In-Process Research and Development and HTML 70K
Other Assets - Additional Information (Detail)
20: R48 Carrying Value of Goodwill and Change in Balance HTML 30K
(Detail)
48: R49 Carrying value of In-Process Research and HTML 29K
Development (Detail)
33: R50 Summary of Other Assets (Detail) HTML 34K
24: R51 Equity Method and Other Investments Classified as HTML 34K
Other Assets (Detail)
51: R52 Carrying value of Equity Method and Other HTML 34K
Investments (Detail)
76: R53 Supplemental Balance Sheet Information Related to HTML 33K
Operating Leases (Detail)
34: R54 Leases - Additional Information (Details) HTML 30K
25: R55 Maturities of Operating Lease Liabilities HTML 49K
(Details)
53: R56 Minimum Future Lease Payments (Detail) HTML 45K
77: R57 Accrued Expenses (Detail) HTML 46K
36: R58 Stockholders' Equity - Additional Information HTML 37K
(Detail)
23: R59 Stockholders' Equity - Schedule of Share HTML 35K
Repurchase Activity (Detail)
67: R60 Stockholders' Equity - Schedule of Accumulated HTML 49K
Other Comprehensive Income (Loss) (Detail)
73: R61 Stock-Based Compensation Recognized (Detail) HTML 35K
46: R62 Summary of Stock Option Activity (Detail) HTML 80K
16: R63 Stock-Based Compensation - Additional Information HTML 56K
(Detail)
68: R64 Summary of Weighted Average Grant-Date Fair Values HTML 40K
And Weighted Average Assumptions Used to Calculate
Fair Value of Options Granted (Detail)
74: R65 Summary of Restricted Stock Units Activity HTML 50K
(Detail)
47: R66 Income Taxes - Additional Information (Detail) HTML 34K
17: R67 Differences Between Statutory Income Tax Rate and HTML 49K
Effective Income Tax Rate (Detail)
66: R68 Commitments and Contingencies - Additional HTML 31K
Information (Detail)
75: R69 Segment and Enterprise Wide Disclosures - HTML 40K
Additional Information (Detail)
13: XML IDEA XML File -- Filing Summary XML 155K
45: XML XBRL Instance -- abmd-10q_20191231_htm XML 3.85M
35: EXCEL IDEA Workbook of Financial Reports XLSX 87K
8: EX-101.CAL XBRL Calculations -- abmd-20191231_cal XML 199K
9: EX-101.DEF XBRL Definitions -- abmd-20191231_def XML 414K
10: EX-101.LAB XBRL Labels -- abmd-20191231_lab XML 1.15M
11: EX-101.PRE XBRL Presentations -- abmd-20191231_pre XML 904K
7: EX-101.SCH XBRL Schema -- abmd-20191231 XSD 156K
56: JSON XBRL Instance as JSON Data -- MetaLinks 322± 521K
52: ZIP XBRL Zipped Folder -- 0001564590-20-003682-xbrl Zip 273K
 | Download this zipped .zip folder |
| Files: | abmd-10q_20191231.htm abmd-20191231.xsd abmd-20191231_cal.xml abmd-20191231_def.xml abmd-20191231_lab.xml abmd-20191231_pre.xml abmd-ex311_8.htm abmd-ex312_6.htm abmd-ex321_663.htm abmd-ex321_7.htm abmd-ex322_665.htm gwq4zbjjvh4p000001.jpg |